Article
Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia.
Biological psychiatry - 1 Jan 2011
Tregellas Jason R, Tanabe Jody, Rojas Donald C, Shatti Shireen, Olincy Ann, Johnson Lynn, Martin Laura F, Soti Ferenc, Kem William R, Leonard Sherry, Freedman Robert
Abstract excerpt
BACKGROUND: 3-(2,4-dimethoxybenzylidene)-anabaseine (DMXB-A) is a partial agonist at α7 nicotinic acetylcholine receptors that has been evaluated clinically for treatment of schizophrenia. This study examined the effects of DMXB-A on default network activity as a biomarker for drug effects on pat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
